Patients’ experiences of continued treatment with extended-release naltrexone: a Norwegian qualitative study

BACKGROUND: The opioid antagonist extended-release naltrexone (XR-NTX) in the treatment of opioid use disorder (OUD) is effective in terms of safety, abstinence from opioid use and retention in treatment. However, it is unclear how patients experience and adjust to losing the possibility of achievin...

Descripción completa

Detalles Bibliográficos
Autores principales: Marciuch, Anne, Brenna, Ida Halvorsen, Weimand, Bente, Solli, Kristin Klemmetsby, Tanum, Lars, Røstad, Bente K., Birkeland, Bente
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290197/
https://www.ncbi.nlm.nih.gov/pubmed/35850782
http://dx.doi.org/10.1186/s13722-022-00317-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290197/
https://www.ncbi.nlm.nih.gov/pubmed/35850782
http://dx.doi.org/10.1186/s13722-022-00317-2

Ejemplares similares